References
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27.
Katzelnick LC, Fonville JM, Gromowski GD, Bustos Arriaga J, Green A, James SL, et al. Dengue viruses cluster antigenically but not as discrete serotypes. Science 2015;349:1338–43.
Fiscus SA, Teramoto YA. Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol 1987;61:2607–13.
Simon LE, Schwartz O. Towards SARS-CoV-2 serotypes? Nat Rev Microbiol 2022;20:187–8.
Tan CW, Chia WN, Zhu F, Young BE, Chantasrisawad N, Hwa SH, et al. SARS-CoV-2 Omicron variant emerged under immune selection. Nat Microbiol 2022;7:1756–61.
Cao YL, Jian FC, Wang J, Yu YL, Song WL, Yisimayi A, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 2022;614:521–9.
Mykytyn AZ, Rissmann M, Kok A, Rosu ME, Schipper D, Breugem TI, et al. Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct. Sci Immunol 2022;7:eabq4450.
Hu SX, Wu CL, Wu XK, Ma XH, Shu C, Chen Q, et al. Classification of five SARS-CoV-2 serotypes based on RBD antigenicities. Sci Bull (Beijing) 2023;68:3003–12.
Tan CW, Zhu F, Chia WN, Young BE, Yeoh AYY, Althaus T, et al. Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individuals. hLife 2023;1:26–34.
Tan CW, Valkenburg SA, Poon LLM, Wang LF. Broad-spectrum pan-genus and pan-family virus vaccines. Cell Host Microbe 2023;31:902–16.
Gretchen V. New subvariants are masters of immune evasion. Science 2022;376:679–80.
Qi ZT, Wu JB, Jiang SB. Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence. Clin Transl Med 2022;12:e924.
